Atrial fibrillation

variety of other conditions; if so, this may result in the person taking aspirin (for the other conditions) as well as anticoagulants. If a person chooses not to take anticoagulants, this decision and the reason(s) for it should be documented. [NICE's 2014 full guideline on atrial fibrillation] Quality statement 3: Discussing options for anticoagulation Quality statement Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year. Rationale Adults with non-valvular atrial fibrillation should have the opportunity to discuss the choice of suitable anticoagulants with their healthcare professional, in order to improve adherence to treatment. Available options should include direct-acting oral anticoagulants and vitamin K antagonists. In adults with valvular atrial fibrillation, only vitamin K antagonists can be used, and this should be explained to the person. Adherence to anticoagulation can help to prevent stroke by reducing the likelihood of a blood clot forming. Quality measures The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly. Structure Evidence of local arrangements to ensure that adults
